Literature DB >> 23102126

Comparison of International Working Group criteria and National Institute on Aging-Alzheimer's Association criteria for Alzheimer's disease.

Pieter Jelle Visser1, Stephanie Vos, Ineke van Rossum, Philip Scheltens.   

Abstract

Two sets of research criteria for Alzheimer's disease are now available: those published by an International Working Group in 2007, and the recommendations published by the National Institute on Aging and the Alzheimer's Association (NIA-AA) in 2011. They both provide guidelines for the diagnosis of asymptomatic and symptomatic Alzheimer's disease. The coexistence of two sets of criteria for the same disorder raises the question of which set of criteria should be preferred. A comparison of the criteria revealed differences in approach, terminology, and use of cognitive markers and biomarkers. Most persons who meet the International Working Group criteria will also meet the NIA-AA criteria and vice versa. However, the NIA-AA criteria allow for a subclassification of persons based on biomarker results within each diagnostic category. Further research is needed to validate the criteria. Modifications are likely to be made before the criteria can be used in daily practice.
Copyright © 2012 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23102126     DOI: 10.1016/j.jalz.2011.10.008

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  12 in total

1.  Temporal evolution of biomarkers and cognitive markers in the asymptomatic, MCI, and dementia stage of Alzheimer's disease.

Authors:  Daniela Bertens; Dirk L Knol; Philip Scheltens; Pieter Jelle Visser
Journal:  Alzheimers Dement       Date:  2014-08-20       Impact factor: 21.566

Review 2.  Use of multimodality imaging and artificial intelligence for diagnosis and prognosis of early stages of Alzheimer's disease.

Authors:  Xiaonan Liu; Kewei Chen; Teresa Wu; David Weidman; Fleming Lure; Jing Li
Journal:  Transl Res       Date:  2018-01-10       Impact factor: 7.012

3.  Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.

Authors:  Stephanie J B Vos; Frans Verhey; Lutz Frölich; Johannes Kornhuber; Jens Wiltfang; Wolfgang Maier; Oliver Peters; Eckart Rüther; Flavio Nobili; Silvia Morbelli; Giovanni B Frisoni; Alexander Drzezga; Mira Didic; Bart N M van Berckel; Andrew Simmons; Hilkka Soininen; Iwona Kłoszewska; Patrizia Mecocci; Magda Tsolaki; Bruno Vellas; Simon Lovestone; Cristina Muscio; Sanna-Kaisa Herukka; Eric Salmon; Christine Bastin; Anders Wallin; Arto Nordlund; Alexandre de Mendonça; Dina Silva; Isabel Santana; Raquel Lemos; Sebastiaan Engelborghs; Stefan Van der Mussele; Yvonne Freund-Levi; Åsa K Wallin; Harald Hampel; Wiesje van der Flier; Philip Scheltens; Pieter Jelle Visser
Journal:  Brain       Date:  2015-02-17       Impact factor: 13.501

4.  Dementia: Mild cognitive impairment--amyloid and beyond.

Authors:  Philip Scheltens
Journal:  Nat Rev Neurol       Date:  2013-07-23       Impact factor: 42.937

5.  The earlier the better: Alzheimer's prevention, early detection, and the quest for pharmacological interventions.

Authors:  Annette Leibing
Journal:  Cult Med Psychiatry       Date:  2014-06

Review 6.  The past and the future of Alzheimer's disease CSF biomarkers-a journey toward validated biochemical tests covering the whole spectrum of molecular events.

Authors:  Kaj Blennow; Henrik Zetterberg
Journal:  Front Neurosci       Date:  2015-09-29       Impact factor: 4.677

7.  Autonomic function in amnestic and non-amnestic mild cognitive impairment: spectral heart rate variability analysis provides evidence for a brain-heart axis.

Authors:  Paola Nicolini; Daniela Mari; Carlo Abbate; Silvia Inglese; Laura Bertagnoli; Emanuele Tomasini; Paolo D Rossi; Federico Lombardi
Journal:  Sci Rep       Date:  2020-07-15       Impact factor: 4.379

8.  A Genetics-based Biomarker Risk Algorithm for Predicting Risk of Alzheimer's Disease.

Authors:  Michael W Lutz; Scott S Sundseth; Daniel K Burns; Ann M Saunders; Kathleen M Hayden; James R Burke; Kathleen A Welsh-Bohmer; Allen D Roses
Journal:  Alzheimers Dement (N Y)       Date:  2016-01-01

Review 9.  Proton Pump Inhibitors and Dementia: Physiopathological Mechanisms and Clinical Consequences.

Authors:  Gloria Ortiz-Guerrero; Diana Amador-Muñoz; Carlos Alberto Calderón-Ospina; Daniel López-Fuentes; Mauricio Orlando Nava Mesa
Journal:  Neural Plast       Date:  2018-03-21       Impact factor: 3.599

Review 10.  Role of Fluid Biomarkers and PET Imaging in Early Diagnosis and its Clinical Implication in the Management of Alzheimer's Disease.

Authors:  Shahul Hameed; Jong-Ling Fuh; Vorapun Senanarong; Esther Gunaseli M Ebenezer; Irene Looi; Jacqueline C Dominguez; Kyung Won Park; Ananda Krishna Karanam; Oliver Simon
Journal:  J Alzheimers Dis Rep       Date:  2020-02-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.